Owkin
Owkin
AI company using federated learning to solve biological complexity and accelerate drug discovery.
About
Technology stack
detected 2026-06-29No comments yet. Be the first to share your take.
What does Owkin do?
Owkin is an AI company focused on solving the complexity of biology to accelerate drug discovery and development. They leverage federated learning and AI to analyze sensitive patient data securely and at scale, enabling better understanding of diseases and identification of new therapeutic targets. Owkin also incubates and spins out companies to bring AI innovations to specific market needs. (formerly ["Owkin Dx"].)
How much funding has Owkin raised?
Owkin has raised a total of $80M in funding. The most recent round on record is Series B.
Where is Owkin headquartered?
Owkin is headquartered in New York, New York, USA.
When was Owkin founded?
Owkin was founded in 2016.
What industry does Owkin operate in?
Owkin operates in Artificial Intelligence, Biotechnology, Healthcare, Drug Discovery, Precision Medicine, AI.
How many employees does Owkin have?
Owkin has approximately 250 people on record.